Clinical Trial Update: Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating subconjunctival triamcinolone injections for upper eyelid retraction in thyroid-associated ophthalmopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid-associated Ophthalmopathy

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Yonsei University | Conditions: Thyroid-associated Ophthalmopathy | Phase 4 | Status: COMPLETED